Рет қаралды 4,765
Jack Aiello is a 28-year multiple myeloma survivor and advocate. He speaks with Dr. Alfred Garfall, a myeloma expert at Penn Medicine, about the latest developments in immunotherapy treatment for multiple myeloma.
They discuss both CAR-T cell therapy and bispecific antibodies as examples of myeloma immunotherapy treatments, with bispecific antibodies being a simpler treatment for patients compared to the more complex process required for CAR-T.
Dr. Garfall explains how bispecifics for multiple myeloma are showing longer remissions and better outcomes for patients.
Full story & transcript → www.thepatientstory.com/medic...
Join Our Community:
Website : www.thepatientstory.com/
Facebook: @ThePatientStory
Instagram: @ThePatientStory
Twitter: @patient_story
#multiplemyeloma #multiplemyelomaawareness #bispecifics #CARTtherapy #CAR-T #cancer #MMSM #thepatientstory #myelomanews #myelomadrugs #cancerpatient